BOSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Cibus, Inc. (NASDAQ:CBUS) for potential securities law violations. Investors who have lost money in their Cibus investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cbus. What is this all about? If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at shareholders@blocklevito ...

BOSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Cibus, Inc. (Nasdaq: CBUS) for potential securities law violations. Investors who have lost money in their Cibus investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cbus. What is this all about? Shares of Cibus fell significantly Tuesday morning after Bonitas Research issued a report alleging that they "found no evidence that Cibus' gene-ed ...

What if I purchased Cibus securities? If you believe that you may have a potential claim against Cibus and would like to participate in the investigation or learn more about your legal rights and options, please contact Johnson Fistel, LLP at (619) 814-4471 or click here to join the investigation online. There is no cost or obligation to you. Click Here to Join the Investigation SAN DIEGO, June 04, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations ...

SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, applauds the Canadian Food Inspection Agency (CFIA), Animal Feed Division's publication of its updated feed guidelines clarifying requirements for new plant varieties developed using applications of gene editing. The guidelines confirm that CFIA intends to fol ...

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer, will host a presentation at the BMO Global Farm to Market Conference taking place May 15-16, 2024. Presentation detailsDa ...

分组1 - 公司正在从一家以研发为主的公司转型为第一家商业化基因编辑公司,正在将验证过的基因编辑性状授权给种子公司,并获得年度专利费 [9][10][11][12] - 公司的基因编辑技术平台RTDS可以在3年内开发出复杂性状,而传统育种或GMO需要10年以上 [18] - 公司已经在油菜和水稻上开发了商业化RTDS平台,并正在开发小麦和大豆平台 [14][15][17][39][40][47] 分组2 - 公司在油菜上的pod shatter reduction性状已经有10家客户,在水稻上的两种除草剂抗性性状HT1和HT3也已经有4家大型客户 [21][32][33][34][35][36] - 除草剂抗性性状在主要作物如玉米、大豆和油菜中占据95%以上的市场份额,这突出了这类性状的巨大需求 [36] - 公司正在开发的高级性状包括抗白粉病和除草剂抗性HT2,其中HT2有望成为第一个达到1亿亩种植面积的基因编辑性状 [43][44][45][46] 问答环节重要的提问和回答 问题1 **Bobby Burleson 提问** 询问欧盟对基因编辑作物的监管进展情况 [60] **Rory Riggs 和 Peter Beetham 回答** 欧洲议会已经投票支持将基因编辑作物的监管与常规育种相同,这是一个重要的转折点。未来6个月内将完成具体法规的制定,预计2025年初就可以在欧洲开展试验和商业化 [61][62][63][64][65][66][67] 问题2 **Carol Cheung 提问** 询问公司的总可寻址市场规模以及未来2-3年的渗透率 [76][77] **Rory Riggs 和 Peter Beetham 回答** 公司的目标市场非常大,如大豆全球种植面积超过5亿亩,其中仅美国和巴西就有2亿亩。公司将采取谨慎的方式估算可寻址市场规模,并逐步渗透,预计到2028年公司的3大性状将全面商业化 [78][79][80][81][82][83][84][85][86][87][88][89] 问题3 **Steve Byrne 提问** 询问公司如何保护知识产权,以及如何应对种子被保存后再次种植的问题 [90] **Peter Beetham 回答** 公司与客户密切合作,采取多种措施保护知识产权,包括利用杂交种子、强大的专利组合以及与客户的合同条款。同时公司也关注终端销售的专利费用问题,这在大豆、油菜等作物中已有先例 [94][95][96][97][98][99][100][101][102]

Cibus (CBUS) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus Estimate of a loss of $1.01. This compares to loss of $5.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.89%. A quarter ago, it was expected that this developer and licensor of plant traits for seed companies would post a loss of $1.12 per share when it actually produced a loss of $1.16, delivering a surprise of -3.57%.Over the las ...

_____________________ FORM 10-Q or Commission file number 001-38161 Securities registered pursuant to Section 12(b) of the Act. Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o If an emerging growth company, indicate by check mark if the reg ...

Important EU Parliament vote on gene editing continues global momentum for the approval of new genomic techniques (NGTs) as similar to conventional breeding Completed single cell regeneration platform for Wheat – with Canola & Rice, Cibus now has its semiautomated crop platform operational for 3 of the top 5 major crops Continued progress with customers toward commercializing Pod Shatter Reduction (PSR) trait in Canola Cibus was recognized by Fast Company as one of the world's most innovative companies of 2 ...

公司介绍 - Cibus, Inc.是一家领先的农业生物技术公司，利用专有的基因编辑技术开发种子中的植物特征[1] - Cibus是一家基因编辑生产力特征领域的领导者，致力于解决农民面临的关键生产力和可持续性挑战，如疾病和害虫，公司不是一家种子公司，而是一家利用基因编辑技术开发和授权特征给种子公司的技术公司，以种子销售的版税作为交换[4] 财务信息 - Cibus将于2024年5月9日公布第一季度财务结果，并将在当天下午4:30举行电话会议和网络直播，讨论财务结果和其他公司更新[1] - 电话会议参与者可以通过拨打电话号码或访问链接参与，无法参加的人士可以在活动结束后通过拨打电话号码和输入回放密码收听回放[2] - 电话会议的现场音频网络直播和相关幻灯片将在公司网站的投资者部分提供，活动结束后的90天内将提供存档的网络直播[3]